SMI Expanded
1.717,62
PKT
+22,26
PKT
+1,31
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.04.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 07.04.05 | Baloise Accumulate | Helvea | |
| 07.04.05 | Swiss Life Sell | Merck Finck & Co | |
| 08.04.05 | Baloise Neutral | Sal. Oppenheim | |
| 07.04.05 | Swiss Life Buy | M.M. Warburg | |
| 08.04.05 | Swiss Prime Site Neutral | Sarasin Research | |
| 08.04.05 | Swiss Life Underperform | Credit Suisse First Boston | |
| 11.04.05 | Swatch (I) Kaufen | NATIONAL-BANK | |
| 06.04.05 | Baloise Accumulate | Helvea | |
| 06.04.05 | Swiss Life Sell | Merck Finck & Co | |
| 06.04.05 | Roche Buy | Helvea | |
| 07.04.05 | Swiss Life Neutral | Sarasin Research | |
| 06.04.05 | Swiss Life Accumulate | Helvea | |
| 07.04.05 | Swiss Life Overweight | Lehman Brothers | |
| 06.04.05 | Swiss Life Overweight | JP Morgan | |
| 06.04.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 05.04.05 | Zurich Insurance Buy | Sarasin Research | |
| 04.04.05 | Swiss Life Overweight | JP Morgan | |
| 05.04.05 | Adecco SA Sell | Dresdner Kleinwort Wasserstein | |
| 04.04.05 | Givaudan Neutral | Sarasin Research | |
| 05.04.05 | Adecco SA Accumulate | Helvea | |
| 04.04.05 | Adecco SA Market Outperform | Vontobel | |
| 04.04.05 | Baloise Buy | Sarasin Research | |
| 04.04.05 | Swiss Life Neutral | Sarasin Research | |
| 01.04.05 | Swisscom Neutral | Helvea | |
| 31.03.05 | Swiss Life Overweight | Lehman Brothers | |
| 01.04.05 | Swiss Life Outperform | HypoVereinsbank | |
| 31.03.05 | Swatch (I) Buy | SYZ & CO | |
| 30.03.05 | Swisscom Neutral | Sarasin Research | |
| 31.03.05 | Swatch (I) Buy | Sarasin Research | |
| 29.03.05 | Roche Buy | Sarasin Research | |
| 29.03.05 | BELIMO Market Perform | Vontobel | |
| 24.03.05 | Roche Sector Outperform | Vontobel | |
| 24.03.05 | Swisscom Neutral | Sarasin Research | |
| 24.03.05 | Swatch (I) Buy | Sarasin Research | |
| 22.03.05 | UBS Buy | Merrill Lynch | |
| 22.03.05 | BELIMO Neutral | Helvea | |
| 22.03.05 | Roche Buy | Sarasin Research | |
| 23.03.05 | UBS Neutral | Merrill Lynch | |
| 22.03.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan |